美股市场个股详情
OGN Organon & Co
- 15.030
- -0.280-1.83%
收盘价 11/15 16:00 (美东)
- 15.290
- +0.260+1.73%
盘后 19:51 (美东)
38.71亿总市值2.98市盈率TTM
15.340最高价14.855最低价283.22万股成交量15.250今开15.310昨收4257.14万成交额1.10%换手率3.77市盈率(静)2.58亿总股本22.69852周最高7.85市净率38.58亿流通值10.19952周最低1.12股息TTM2.57亿流通股33.964历史最高7.45%股息率TTM3.17%振幅10.199历史最低15.031平均价1股每手
关于Organon & Co公司
Organon & Co 是一家以科学为基础的全球制药公司，通过妇女保健，生物仿制药和知名品牌的处方治疗组合，开发和提供健康解决方案。 公司的业务包括以下产品组合： 妇女保健，生物仿制药和成熟药品。从地域上看，公司大部分收入来自欧洲和加拿大，其次是美国，再次是亚太地区和日本。公司的大部分收入来自成熟品牌产品组合。
公司介绍
公司代码OGN
公司名称Organon & Co
上市日期2021/05/14
成立日期2020
CEOMr. Kevin Ali
所属市场纽交所
员工数量10000
年结日12-31
公司地址30 Hudson Street,33rd floor
城市Jersey City
省份新泽西
国家美国
邮编07302
电话1-551-430-6900
董事高管
- 姓名
- 职务
- 年薪
- Kevin Ali
- Chief Executive Officer and Director
- 1483.23万
- Dr. Juan Camilo Arjona Ferreira, M.D.
- Executive Vice President, Head of Research and Development and Chief Medical Officer
- --
- Rachel A. Stahler
- Executive Vice President and Chief Information Officer
- --
- Matthew M. Walsh
- Executive Vice President and Chief Financial Officer
- 521.29万
- Aaron Falcione
- Executive Vice President and Chief Human Resources Officer
- --
- Susanne Fiedler
- Executive Vice President and Chief Commercial Officer
- 383.64万
- Vittorio Nisita
- Executive Vice President and Head of Global Business Services
- --
- Kirke Weaver
- Executive Vice President, General Counsel and Corporate Secretary
- 319.27万
- Joseph T. Morrissey, Jr
- Executive Vice President and Head of Manufacturing and Supply
- 373.70万
- Carrie S. Cox
- Chairman of the Board
- 45.00万
- Shalini Sharp
- Independent Director
- 34.50万
- Martha E. McGarry
- Independent Director
- 32.00万
- Robert A. Essner
- Independent Director
- 33.50万
- Dr. Alan Ezekowitz, D.Phil.,MB.Ch.B.
- Independent Director
- 33.00万
- Cynthia M. Patton
- Independent Director
- 33.00万
- Rochelle B. Lazarus
- Independent Director
- 32.00万
- Grace Puma Whiteford
- Independent Director
- 32.00万
- Deborah R. Leone
- Independent Director
- 33.00万
- Dr. Phillip Ozuah, M.D.,PhD
- Independent Director
- 32.00万
- Dr. Helene D. Gayle, M.D.
- Independent Director
- 32.00万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据